Finance

Beta
Lists
300702:SHE
Zhejiang Tianyu Pharmaceutical Co Ltd
CNÂ¥19.18
+6.03%
(+1.09) 1D
Jun 5, 3:04:55 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300702...
Open
CNÂ¥18.26
High
CNÂ¥19.79
Low
CNÂ¥18.01
Mkt. cap
6.67B
Avg. vol.
3.45M
Volume
5.84M
Dividend
0.26%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 2, 2026
P/E ratio
79.06
52-wk high
CNÂ¥31.20
52-wk low
CNÂ¥17.98
EPS
CNÂ¥0.24
Shares outstanding
347.98M
No. of employees
5K
Open
CNÂ¥18.26
High
CNÂ¥19.79
Low
CNÂ¥18.01
Mkt. cap
6.67B
Avg. vol.
3.45M
Volume
5.84M
Dividend
0.26%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 2, 2026
P/E ratio
79.06
52-wk high
CNÂ¥31.20
52-wk low
CNÂ¥17.98
EPS
CNÂ¥0.24
Shares outstanding
347.98M
No. of employees
5K
News stories
From sources across the web
About Zhejiang Tianyu Pharmaceutical Co Ltd
CEO-
Employees4.69K
Founded1993
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
808.11M
719.55M
774.15M
811.67M
Cost of goods sold
553.56M
362.88M
604.51M
548.33M
Cost of revenue
553.56M
362.88M
604.51M
548.33M
Research and development expenses
62.97M
63.23M
60.66M
52.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
122.61M
142.58M
207.09M
123.93M
Operating expense
205.92M
201.10M
283.89M
178.76M
Total operating expenses
759.47M
563.98M
888.40M
727.09M
Operating income
48.63M
155.57M
-114.24M
84.58M
Other non operating income
-7.50M
3.16M
-8.84M
-12.56M
EBT including unusual items
63.69M
75.38M
-76.40M
46.43M
EBT excluding unusual items
40.82M
140.34M
-129.49M
63.99M
Income tax expense
360.50K
3.96M
4.82M
4.24M
Effective tax rate
0.57%
5.25%
-6.31%
9.13%
Other operating expenses
9.11M
4.28M
12.54M
2.51M
Net income
63.33M
71.42M
-81.22M
42.19M
Net profit margin
7.84%
9.93%
-10.49%
5.20%
Earnings per share
-
-
-
-
Interest and investment income
2.69M
807.20K
1.50M
1.45M
Interest expense
-11.28M
-10.92M
-9.63M
-9.48M
Net interest expenses
-8.60M
-10.11M
-8.13M
-8.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
133.85M
235.92M
-27.39M
171.43M
Gain or loss from assets sale
125.02K
-125.02K
434.71K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more